electroCore, Inc. (NASDAQ:ECOR) was the target of a large growth in short interest in October. As of October 31st, there was short interest totalling 1,600,000 shares, a growth of 11.1% from the September 30th total of 1,440,000 shares. Approximately 7.3% of the company’s stock are short sold. Based on an average daily volume of 223,700 shares, the short-interest ratio is presently 7.2 days.
A number of equities research analysts have issued reports on ECOR shares. Zacks Investment Research downgraded shares of electroCore from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. BTIG Research reaffirmed a “hold” rating on shares of electroCore in a research report on Wednesday, August 14th. JMP Securities downgraded shares of electroCore from an “outperform” rating to a “market perform” rating in a research report on Thursday. ValuEngine raised shares of electroCore from a “hold” rating to a “buy” rating in a research report on Thursday, August 1st. Finally, Evercore ISI reaffirmed a “buy” rating and issued a $9.00 price objective on shares of electroCore in a research report on Wednesday. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $6.95.
ECOR stock traded up $0.10 during trading on Friday, reaching $1.58. The stock had a trading volume of 185,600 shares, compared to its average volume of 144,152. The company has a market capitalization of $43.80 million, a price-to-earnings ratio of -1.33 and a beta of 2.42. The company has a quick ratio of 5.93, a current ratio of 6.63 and a debt-to-equity ratio of 0.04. The company’s 50 day moving average is $1.95 and its two-hundred day moving average is $2.42. electroCore has a one year low of $1.23 and a one year high of $10.24.
electroCore (NASDAQ:ECOR) last announced its quarterly earnings results on Wednesday, November 13th. The company reported ($0.36) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.31) by ($0.05). The company had revenue of $0.68 million for the quarter. As a group, research analysts predict that electroCore will post -1.43 earnings per share for the current fiscal year.
A number of hedge funds and other institutional investors have recently bought and sold shares of ECOR. Valeo Financial Advisors LLC lifted its stake in electroCore by 101.6% in the 2nd quarter. Valeo Financial Advisors LLC now owns 26,000 shares of the company’s stock worth $52,000 after purchasing an additional 13,100 shares in the last quarter. Bfsg LLC lifted its stake in electroCore by 205.9% in the 2nd quarter. Bfsg LLC now owns 52,000 shares of the company’s stock worth $104,000 after purchasing an additional 35,000 shares in the last quarter. Brighton Jones LLC lifted its stake in electroCore by 49.2% in the 2nd quarter. Brighton Jones LLC now owns 45,471 shares of the company’s stock worth $91,000 after purchasing an additional 15,000 shares in the last quarter. Rockefeller Capital Management L.P. purchased a new stake in electroCore in the 2nd quarter worth approximately $28,000. Finally, Bronfman E.L. Rothschild L.P. purchased a new stake in electroCore in the 2nd quarter worth approximately $50,000. Institutional investors and hedge funds own 9.91% of the company’s stock.
electroCore Company Profile
electroCore, Inc, a bioelectronic medicine company, engages in developing a range of patient-administered non-invasive vagus nerve (VNS) stimulation therapies for the treatment of various conditions in neurology, rheumatology, and other fields. The company is developing gammaCore, a prescription-only non-invasive VNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults.
Read More: Day Trading
Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.